ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 134033 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 134033; 2) Community: the network communities that were significantly associated with the response to NSC 134033; 3) Molecule: the relationships between components within communities and NSC 134033; 4) MDR: the compounds that were significantly associated with the NSC 134033.

NSC Compound Enrichment Correlation
NSC 736164 pyrazoline derivative 0.000174252554411806 0.32625991
NSC 728132 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,4-dichlorobenzene 0.000237457299255281 0.14351305
NSC 208652 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- 0.000241980579444665 0.71697091
NSC 30863 Null 0.000241980579444665 0.25875096
NSC 58905 9H-Purine, 9-(2-chloroethyl)-6-[(phenylmethyl)thio]- (9CI) 0.000241980579444665 0.43278062
NSC 726441 4,11-dihydroxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-naphtho [2,3-f]indole-5,10-dione dihydrochloride 0.000241980579444665 0.2978093
NSC 683326 Null 0.000260156221906648 0.29943909
NSC 174121 Methotrexate Derivative 0.000272379738694983 0.87645574
NSC 271674 Carboxyphthalatoplatinum 0.000272379738694983 0.53418756
NSC 272346 1,7-Heptanediamine, N,N'-bis(2-methyl-7-nitro-4-quinolinyl)-, dihydrochloride 0.000272379738694983 0.37062959
Total:115  Current:2    [First] [Prev] [Next] [Last]